Advertisements


Curbing disease

Across the developing world, disease causes a vast toll of avoidable suffering.....»»

Category: economicsSource: economistJul 28th, 2018

Curbing disease

Across the developing world, disease causes a vast toll of avoidable suffering.....»»

Category: economicsSource: economistJul 28th, 2018

From shrimp shell polymers to new cures for cardiovascular disease: Alabama’s world-changing innovation didn’t stop after Carver’s peanuts

When you think of Alabama technology, you may conjure sepia-toned images of George Washington Carver’s zany peanut inventions or grainy footage of the first moon landing, achieved with the Saturn V rocket built on Alabama soil. What you may not.....»»

Category: topSource: bizjournalsApr 17th, 2024

Rare Disease-Focused-Ultragenyx Pharmaceutical Stock Falls On Serious Adverse Events In Eaarly Genetic Disorder Study

New data from Phase 1/2 study of GTX-102 for Angelman syndrome shows rapid and sustained improvement in patients, exceeding natural history data. read more.....»»

Category: blogSource: benzingaApr 15th, 2024

Atrium Health Wake Forest Baptist treats first local patient with FDA-approved Alzheimer’s disease drug

On March 14, 2024, Atrium Health Wake Forest Baptist became the first health system in the region to treat a patient with lecanemab, a new medication for Alzheimer’s disease. This is the first Alzheimer’s drug approved by the FDA in more than 20 .....»»

Category: topSource: bizjournalsApr 14th, 2024

CDC Study Doesn"t "Debunk" Link Between COVID-19 Vaccines & Sudden-Deaths

CDC Study Doesn't 'Debunk' Link Between COVID-19 Vaccines & Sudden-Deaths Authored by Zachary Stieber via The Epoch Times, A new U.S. Centers for Disease Control and Prevention (CDC) st.....»»

Category: personnelSource: nytApr 13th, 2024

Vertex Pharmaceutical"s Move Beyond Its $10B Cystic Fibrosis Franchise, Pays Around $5B For Kidney Disease Player Alpine Immune

Vertex Pharma.....»»

Category: blogSource: benzingaApr 11th, 2024

Boston company to buy Alpine Immune Sciences for $4.9B

The Seattle biotech is developing a drug to treat kidney disease......»»

Category: topSource: bizjournalsApr 11th, 2024

Cartesian Therapeutics" Rare Disease Candidate Shows Long Lasting Benefit Over Argenx"s Vyvgart, Analyst Initiates With Buy

Cartesian Therapeutics' autoimmu.....»»

Category: blogSource: benzingaApr 10th, 2024

Ginkgo Bioworks aims to use AI to predict measles outbreaks, thanks to the Gates Foundation

This year has seen outbreaks of the highly contagious disease more than two decades after the CDC declared it eliminated from the U.S......»»

Category: topSource: bizjournalsApr 10th, 2024

US cuts Mexico"s aviation safety rating, curbing new flights

Mexico's aviation safety rating was downgraded Tuesday by U.S. regulators......»»

Category: topSource: foxnewsMay 26th, 2021

Column: California"s stem cell program found a disease cure, but it"s being blocked by a biotech firm

A biotech firm has halted work on a state-funded disease cure, purely for its bottom line.A biotech firm has halted work on a state-funded disease cure, purely for its bottom line......»»

Category: topSource: latimesMay 24th, 2021

Eli Lilly says mirikizumab improved fatigue in Crohn"s disease at 12 weeks

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 22nd, 2021

Experts say it"s too convenient for politicians to blame COVID-19 outbreaks on variants - we have the tools fight them, we just need to use them

The current variants may help the coronavirus spread better, but the virus hasn't changed enough to render our disease-fighti.....»»

Category: personnelSource: nytMay 22nd, 2021

: Booster dose of COVID vaccines to be given to U.K. volunteers in new trial

Thousands of volunteers will be given a third dose of COVID-19 vaccines as part of a clinical trial to examine whether a “booster” shot can protect against COVID-19 and new coronavirus disease variants......»»

Category: topSource: marketwatchMay 20th, 2021

Anthony Fauci said the US can prevent another COVID surge if 70% of the population gets at least one vaccine shot by July 4

Fauci said COVID-19 vaccines authorized by the Centers for Disease Control and Pre.....»»

Category: smallbizSource: nytMay 20th, 2021

Nordstrom joins other retailers in allowing vaccinated shoppers to go maskless

Its policy falls in line with new guidance last week from the Centers for Disease Control and Prevention......»»

Category: topSource: bizjournalsMay 20th, 2021

A pediatric infectious disease expert answers 7 common questions about children getting the COVID-19 vaccine

The FDA expanded emergency use of the Pfizer-BioNTech vaccine to children aged 12 to 15 on May 10, and so far no severe reactions have been reported. Charles Muro, age 13, celebrates being ino.....»»

Category: topSource: businessinsiderMay 19th, 2021

Novo Nordisk Phase 2 ziltivekimab trial met endpoints in kidney disease

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 17th, 2021

CDC: 3 million teens between ages of 12 and 17 have received at least one COVID-19 shot

More than 3 million teens between the ages of 12 and 17 years old have gotten at least one COVID-19 shot, as of Monday, according to the Centers for Disease Control and Pr.....»»

Category: topSource: marketwatchMay 17th, 2021

Fortress Biotech Reports First Quarter 2021 Financial Results and Recent Corporate Highlights

Rolling NDA submission for CUTX-101 for the treatment of Menkes disease is expected to begin in the second half of 2021 On track to report top-line results from the registration-enabling study of cosibelimab in metastatic cutaneous squ.....»»

Category: dealsSource: nytMay 16th, 2021